GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Corp (XTER:PSH) » Definitions » FCF Margin %

Sernova (XTER:PSH) FCF Margin %

: 0.00% (As of Jan. 2024)
View and export this data going back to 2021. Start your Free Trial

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Sernova's Free Cash Flow for the three months ended in Jan. 2024 was C$-4.25 Mil. Sernova's Revenue for the three months ended in Jan. 2024 was C$0.00 Mil. Therefore, Sernova's FCF Margin % for the quarter that ended in Jan. 2024 was 0.00%.

As of today, Sernova's current FCF Yield % is -21.35%.

The historical rank and industry rank for Sernova's FCF Margin % or its related term are showing as below:


XTER:PSH's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -149.63
* Ranked among companies with meaningful FCF Margin % only.


Sernova FCF Margin % Historical Data

The historical data trend for Sernova's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
FCF Margin %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sernova Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
FCF Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Biotechnology subindustry, Sernova's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sernova FCF Margin % Distribution

For the Biotechnology industry and Healthcare sector, Sernova's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Sernova's FCF Margin % falls into.



Sernova FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Sernova's FCF Margin for the fiscal year that ended in Oct. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Oct. 2023 )/Revenue (A: Oct. 2023 )
=-30.438/0
= %

Sernova's FCF Margin for the quarter that ended in Jan. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Jan. 2024 )/Revenue (Q: Jan. 2024 )
=-4.248/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sernova FCF Margin % Related Terms

Thank you for viewing the detailed overview of Sernova's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sernova (XTER:PSH) Business Description

Traded in Other Exchanges
Address
700 Collip Circle, The Stiller Centre, Suite 114, London, ON, CAN, N6G 4X8
Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and or hormones for the long-term treatment of multiple serious, chronic diseases such as diabetes, hemophilia, and thyroid disease.

Sernova (XTER:PSH) Headlines